Current Molecular Medicine is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Andras Guttman (University of Pannonia). The journal covers research on molecular mechanisms of disease pathogenesis, the development of molecular diagnosis, and/or novel approaches to rational treatment. Formats of publication include original research reports, review papers, and rapid communications ("letters").[1]
| Discipline | Molecular medicine |
|---|---|
| Language | English |
| Edited by | Andras Guttman |
| Publication details | |
| History | 2001–present |
| Publisher | |
| Frequency | 9/year |
| 2.222 (2021) | |
| Standard abbreviations | |
| ISO 4 | Curr. Mol. Med. |
| Indexing | |
| CODEN | CMMUBP |
| ISSN | 1566-5240 (print) 1875-5666 (web) |
| OCLC no. | 47091629 |
| Links | |
Abstracting and indexing edit
Current Molecular Medicine is indexed in the following databases:[2][3]
According to Journal Citation Reports, the journal has a 2020 impact factor of 2.222.[4]
References edit
- ^ "Journal overview". Current Molecular Medicine. Bentham Science Publishers. July 2021. Archived from the original on 2011-07-31. Retrieved 2021-07-26.
- ^ "List of indexing services". Current Molecular Medicine. Bentham Science Publishers. August 2011. Archived from the original on 2011-07-31. Retrieved 2011-08-04.
- ^ "Current Molecular Medicine". CAS Source Index (CASSI). American Chemical Society. August 2011. Retrieved 2011-08-04.
- ^ "Journals Ranked by Impact: Medicine, Research & Experimental". 2020 Journal Citation Reports (Science ed.). Clarivate. 2021.
{{cite book}}:|work=ignored (help)